Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-01-23 @ 2:14 PM
Study NCT ID:
NCT00028002
Status:
COMPLETED
Last Update Posted:
2020-10-26
First Post:
2001-12-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastrointestinal Stromal Tumor | View |
Keywords: